This patient should undergo genetic biomarker testing. The National Comprehensive Cancer Network (NCCN) guidelines recommend genetic testing of all likely adenocarcinomas of the lung. Furthermore, the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice guidelines contain detailed recommendations about the target population (all patients with lung adenocarcinoma regardless of clinical indicators such as smoking status, race, or sex), the recommended testing approaches, and a recommended turnaround time of less than 14 days.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: John C. Leighton Jr. Skill Checkup: A 53-Year-Old Woman With Dry Cough and a Lung Lesion - Medscape - Sep 01, 2022.
Comments